U S Physical Therapy Inc Revenue Growth Rates (USPH), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
U S Physical Therapy Inc  (NYSE: USPH)
 

USPH's Revenue Growth by Quarter and Year

U S Physical Therapy Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/USPH/growth
https://api.csimarket.com/api/v1/companies/USPH/fundamentals
https://api.csimarket.com/api/v1/companies/USPH/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
USPH Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 222.56
2nd Quarter June 214.06
1st Quarter March 198.29
FY 634.91

USPHs Annual Revenue
U S Physical Therapy Inc's Revenue in the fiscal year 2025 $ 780.99 millions
U S Physical Therapy Inc's Revenue in the fiscal year 2024 $ 671.35 millions
U S Physical Therapy Inc's Revenue in the fiscal year 2023 $ 604.80 millions
U S Physical Therapy Inc's Revenue in the fiscal year 2022 $ 112.02 millions
U S Physical Therapy Inc's Revenue in the fiscal year 2021 $ 495.02 millions




USPH Revenue third quarter 2026 Y/Y Growth Comment
U S Physical Therapy Inc reported Revenue increase of 12.9% year on year in the third quarter 2026, to $ 222.56 millions, this is lower than U S Physical Therapy Inc's recent average Revenue improvement of 20.61%.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 98 other companies have achieved higher Revenue growth. While U S Physical Therapy Inc' s Revenue growth of 12.9% ranks overall at the positon no. 1897 in the third quarter 2026.


USPH Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 12.9 %
2nd Quarter June 8.47 %
1st Quarter March 7.89 %
FY   -

Financial Statements
U S Physical Therapy Inc's third quarter 2026 Revenue $ 222.56 millions USPH's Income Statement
U S Physical Therapy Inc's third quarter 2025 Revenue $ 197.13 millions Quarterly USPH's Income Statement


USPH Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 3.97 %
2nd Quarter June 7.95 %
1st Quarter March -2.19 %
FY (Year on Year)   -


Back to USPH Growth rate Comparisons >> Back to USPH Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #99
Healthcare Sector #289
Overall #1897

Revenue Y/Y Growth Statistics
High Average Low
460.06 % 20.61 % -78.72 %
(Jun 30 2024)   (Mar 31 2023)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #99
Healthcare Sector #289
Overall #1897
Revenue Y/Y Growth Statistics
High Average Low
460.06 % 20.61 % -78.72 %
(Jun 30 2024)   (Mar 31 2023)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

U S Physical Therapy Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
427.11 % 12.86 % -80.96 %
(Dec 31 2022)  


USPH's III. Quarter Q/Q Revenue Comment
U S Physical Therapy Inc achieved in the III. Quarter 2026 below company average Revenue growth of 3.97% quarter on quarter, to $ 222.56 millions.

Although the III. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the III. Quarter surge, eclipses the -0.11% growth in the III. Quarter a year ago

Within Medical Equipment & Supplies industry 40 other companies have achieved higher Revenue quarter on quarter growth. While U S Physical Therapy Inc's Revenue growth quarter on quarter, overall rank is 938.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #41
Healthcare Sector #144
Overall #938
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #41
Healthcare Sector #144
Overall #938
Revenue Q/Q Growth Statistics
High Average Low
427.11 % 12.86 % -80.96 %
(Dec 31 2022)  


USPH's III. Quarter Q/Q Revenue Comment
U S Physical Therapy Inc achieved in the III. Quarter 2026 below company average Revenue growth of 3.97% quarter on quarter, to $ 222.56 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -0.11% in the III. Quarter a year ago.

Within Medical Equipment & Supplies industry 40 other companies have achieved higher Revenue quarter on quarter growth. While U S Physical Therapy Inc's Revenue growth quarter on quarter, overall rank is 938.


U S Physical Therapy Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 837.63
Y / Y Revenue Growth (TTM) 10.4 %
Year on Year Revenue Growth Overall Ranking # 814
Seqeuential Revenue Change (TTM) 3.13 %
Seq. Revenue Growth (TTM) Overall Ranking # 2035


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2026 period, U S Physical Therapy Inc's cumulative twelve months Revenue were $ 838 millions, company would post below average annual Revenue growth of 3.13% year on year, if the fiscal year would end at Sep 30 2026.
A slow-down in the U S Physical Therapy Inc's Revenue growth from the 214.06% growth in Jun 30 2026.

In the Healthcare sector 173 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 274 to 814.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 109
Healthcare Sector # 174
Overall # 814

Revenue TTM Y/Y Growth Statistics
High Average Low
176.11 %
 14.25 %
-56.04 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 109
Sector # 304
S&P 500 # 2035
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2026 period, U S Physical Therapy Inc's cumulative twelve months Revenue were $ 838 millions, company would post below average annual Revenue growth of -56.04% year on year, if the fiscal year would end at Sep 30 2026.
A slow-down in the U S Physical Therapy Inc's Revenue growth from the 214.06% growth in Jun 30 2026.

In the Healthcare sector 173 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 274 to 814.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 109
Healthcare Sector # 174
Overall # 814

Revenue TTM Y/Y Growth Statistics
High Average Low
176.11 %
14.25 %
-56.04 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 109
Sector # 304
S&P 500 # 2035




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
USPH's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Capsovision Inc 22.44%$ 22.443 millions
Veracyte Inc 22.10%$ 22.105 millions
Radnet Inc 22.07%$ 22.068 millions
Alkermes Plc 21.80%$ 21.804 millions
Alpha Teknova Inc 21.52%$ 21.523 millions
Anteris Technologies Global Corp 20.98%$ 20.979 millions
Trisalus Life Sciences Inc 20.81%$ 20.807 millions
Orthopediatrics Corp20.55%$ 20.551 millions
Alpha Pro Tech Ltd 19.73%$ 19.729 millions
Insulet Corporation19.21%$ 19.213 millions
Abcellera Biologics Inc 18.81%$ 18.805 millions
Schrodinger Inc 18.72%$ 18.715 millions
Procept Biorobotics Corporation18.41%$ 18.414 millions
Supernus Pharmaceuticals inc 18.05%$ 18.047 millions
Harvard Apparatus Regenerative Technology Inc 17.89%$ 17.886 millions
Outset Medical Inc 17.51%$ 17.510 millions
Alnylam Pharmaceuticals Inc 16.74%$ 16.738 millions
IMPACT BIOMEDICAL INC.16.67%$ 16.667 millions
Rigel Pharmaceuticals Inc16.45%$ 16.452 millions
Si bone inc 16.42%$ 16.424 millions
Ars Pharmaceuticals Inc 16.03%$ 16.027 millions
Atricure Inc 15.84%$ 15.839 millions
American Shared Hospital Services15.76%$ 15.761 millions
Ardelyx inc 15.70%$ 15.704 millions
Novocure Limited15.67%$ 15.666 millions
Penumbra Inc15.64%$ 15.636 millions
Orasure Technologies Inc15.45%$ 15.445 millions
Electromed Inc 15.34%$ 15.342 millions
Irhythm Holdings Inc 15.34%$ 15.339 millions
P3 Health Partners Inc 14.80%$ 14.798 millions


About U S Physical Therapy Inc Revenue Growth Rates (USPH), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: U S Physical Therapy Inc Nv (CIK 885978).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001140361-26-042104
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: U S Physical Therapy Inc Nv’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.